{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:44:21Z","timestamp":1790027061598,"version":"4.0.1"},"reference-count":63,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T00:00:00Z","timestamp":1064188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver International"],"published-print":{"date-parts":[[2003,10]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold>Bile salts take part in an efficient enterohepatic circulation in which most of the secreted bile salts are reclaimed by absorption in the terminal ileum. In the liver, the sodium\u2010dependent taurocholate transporter at the basolateral (sinusoidal) membrane and the bile salt export pump at the canalicular membrane mediate hepatic uptake and hepatobiliary secretion of bile salts. Canalicular secretion is the driving force for the enterohepatic cycling of bile salts and most genetic diseases are caused by defects of canalicular secretion. Impairment of bile flow leads to adaptive changes in the expression of transporter proteins and enzymes of the cytochrome P\u2010450 system involved in the metabolism of cholesterol and bile acids. Bile salts act as ligands for transcription factors. As such, they stimulate or inhibit the transcription of genes encoding transporters and enzymes involved in their own metabolism. Together these changes appear to serve mainly a hepatoprotective function. Progressive familial intrahepatic cholestasis (PFIC) results from mutations in various genes encoding hepatobiliary transport proteins. Mutations in the<jats:italic>FIC1<\/jats:italic>gene cause relapsing or permanent cholestasis. The relapsing type of cholestasis is called benign recurrent intrahepatic cholestasis, the permanent type of cholestasis PFIC type 1. PFIC type 2 results from mutations in the bile salt export pump (<jats:italic>BSEP<\/jats:italic>) gene. This is associated with permanent cholestasis since birth. Serum gamma\u2010glutamyltransferase (gamma\u2010GT) activity is low to normal in PFIC types 1 and 2. Bile diversion procedures, causing a decreased bile salt pool, have a beneficial effect in a number of patients with these diseases. However, liver transplantation is often necessary. PFIC type 3 is caused by mutations in the<jats:italic>MDR3<\/jats:italic>gene. MDR3 is a phospholipid translocator in the canalicular membrane. Because of the inability to secrete phospholipids, patients with PFIC type 3 produce bile acid\u2010rich toxic bile that damages the intrahepatic bile ducts. Serum gamma\u2010GT activity is elevated in these patients. Ursodeoxycholic acid therapy is useful for patients with a partial defect. Liver transplantation is a more definitive therapy for these patients.<\/jats:p>","DOI":"10.1034\/j.1478-3231.2003.00856.x","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T07:54:30Z","timestamp":1064217270000},"page":"315-322","source":"Crossref","is-referenced-by-count":85,"title":["Genetic cholestasis, causes and consequences for hepatobiliary transport"],"prefix":"10.1111","volume":"23","author":[{"given":"Peter L. M.","family":"Jansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Sturm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,9,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9426"},{"issue":"6","key":"e_1_2_6_3_2","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/0016-5085(94)90821-4","article-title":"In situ localization of the hepatocytic Na+\/taurocholate cotransporting polypeptide in rat liver","volume":"107","author":"Stieger B","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.21176"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.16.10046"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(99)00460-6"},{"issue":"1","key":"e_1_2_6_7_2","first-page":"24","article-title":"Cloning and expression of murine sister of P\u2010glycoprotein reveals a more discriminating transporter than MDR1\/P\u2010glycoprotein","volume":"57","author":"Lecureur V","year":"2000","journal-title":"Mol Pharmacol"},{"issue":"4","key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1073\/pnas.98.4.2011","article-title":"Targeted inactivation of sister of P\u2010glycoprotein gene (spgp) in mice results in nonprogressive but persistent intrahepatic cholestasis","volume":"98","author":"Wang R","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.4.2905"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20021886"},{"issue":"3","key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"G438","DOI":"10.1152\/ajpgi.2000.278.3.G438","article-title":"Characterization of inducible nature of MRP3 in rat liver","volume":"278","author":"Ogawa K","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M106340200"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119355"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.45.27228"},{"issue":"10","key":"e_1_2_6_15_2","first-page":"7218","article-title":"Transporters on demand","volume":"276","author":"Kipp H","year":"2001","journal-title":"intrahepatic pools of canalicular ATP binding cassette transporters in rat liver"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M011610200"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)00050-2"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.25503"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00062-3"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8536857"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1534-5807(02)00154-5"},{"key":"e_1_2_6_22_2","doi-asserted-by":"crossref","unstructured":"HoltJ A LuoG BillinA N BisiJ McNeillY Y KozarskyK F et al. Definition of a novel growth factor\u2010dependent signal cascade for the suppression of bile acid synthesis. Genes Dev2003;17:1581\u201391.","DOI":"10.1101\/gad.1083503"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.22646"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.35948"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M104612200"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","unstructured":"BohanA ChenS\u2010W DensonL A HeldM A BoyerJ L.TNF alpha dependent up\u2010regulation of Lrh\u20101 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. J Biol Chem 2003 in press.","DOI":"10.1074\/jbc.M304011200"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9384"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0398-219"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.282"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)77221-4"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.23947"},{"key":"e_1_2_6_32_2","first-page":"777","article-title":"Cystic fibrosis","volume":"29","author":"Zielenski J","year":"1995","journal-title":"genotypic and phenotypic variations"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/3.2.265"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250635"},{"issue":"5","key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/hep.510230519","article-title":"Absence of the canalicular isoform of the MRP gene\u2010encoded conjugate export pump from the hepatocytes in Dubin\u2013Johnson syndrome","volume":"23","author":"Kartenbeck J","year":"1996","journal-title":"Hepatology"},{"issue":"1","key":"e_1_2_6_36_2","first-page":"155","article-title":"Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease [PFIC\u20101] and Byler syndrome)","volume":"26","author":"Bull L N","year":"1997","journal-title":"evidence for heterogeneity"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199402000-00002"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.75.3.223"},{"issue":"3","key":"e_1_2_6_39_2","first-page":"378","article-title":"Progressive familial intrahepatic cholestasis (PFIC)","volume":"100","author":"Arnell H","year":"1997","journal-title":"evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21\u2013q22"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199705000-00011"},{"issue":"4","key":"e_1_2_6_41_2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/02724936.1995.11747792","article-title":"Progressive familial intrahepatic cholestasis (Byler's disease) in Arab children","volume":"15","author":"Kagalwalla A F","year":"1995","journal-title":"Ann Trop Paediatr"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8628(20001218)95:5<450::AID-AJMG8>3.0.CO;2-V"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198910000-00011"},{"issue":"9","key":"e_1_2_6_44_2","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1572-0241.1998.00472.x","article-title":"Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma\u2010glutamyl transpeptidase","volume":"93","author":"Cancado E L","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"e_1_2_6_45_2","first-page":"483","article-title":"Benign recurrent intrahepatic cholestasis","volume":"36","author":"Balsells F","year":"1997","journal-title":"improvement of pruritus and shortening of the symptomatic phase with rifampin therapy: a case report"},{"issue":"3","key":"e_1_2_6_46_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/3034","article-title":"A gene encoding a liver\u2010specific ABC transporter is mutated in progressive familial intrahepatic cholestasis","volume":"20","author":"Strautnieks S S","year":"1998","journal-title":"Nat Genet"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70287-8"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230435"},{"issue":"6","key":"e_1_2_6_49_2","first-page":"1448","article-title":"The wide spectrum of multidrug resistance 3 deficiency","volume":"120","author":"Jacquemin E","year":"2001","journal-title":"from neonatal cholestasis to cirrhosis of adulthood"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510250303"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.1999.01921.x"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3468(95)90440-9"},{"issue":"12","key":"e_1_2_6_53_2","first-page":"3522","article-title":"Progressive familial intrahepatic cholestasis","volume":"95","author":"Melter M","year":"2000","journal-title":"partial biliary diversion normalizes serum lipids and improves growth in noncirrhotic patients"},{"key":"e_1_2_6_54_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-199902000-00026"},{"issue":"1","key":"e_1_2_6_55_2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0016-5085(88)90301-0","article-title":"Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis","volume":"95","author":"Whitington P F","year":"1988","journal-title":"Gastroenterology"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199011000-00012"},{"issue":"8","key":"e_1_2_6_57_2","first-page":"1209","article-title":"Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy","volume":"9","author":"Dixon P H","year":"2000","journal-title":"evidence for a defect in protein trafficking"},{"issue":"2","key":"e_1_2_6_58_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0016-5085(76)80187-4","article-title":"Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives","volume":"71","author":"De Pagter A G","year":"1976","journal-title":"Gastroenterology"},{"issue":"3","key":"e_1_2_6_59_2","first-page":"504","article-title":"Ursodeoxycholic acid administration in patients with cholestasis of pregnancy","volume":"33","author":"Mazzella G","year":"2001","journal-title":"effects on primary bile acids in babies and mothers"},{"issue":"6","key":"e_1_2_6_60_2","first-page":"1022","article-title":"Ursodeoxycholic acid in the treatment of cholestasis of pregnancy","volume":"27","author":"Palma J","year":"1997","journal-title":"a randomized, double-blind study controlled with placebo"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365529850170955"},{"key":"e_1_2_6_62_2","doi-asserted-by":"publisher","DOI":"10.1086\/303080"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.148"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1147"}],"container-title":["Liver International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1478-3231.2003.00856.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1478-3231.2003.00856.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1478-3231.2003.00856.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T21:09:43Z","timestamp":1734124183000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1478-3231.2003.00856.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9,22]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["10.1034\/j.1478-3231.2003.00856.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1478-3231.2003.00856.x","archive":["Portico"],"relation":{},"ISSN":["1478-3223","1478-3231"],"issn-type":[{"value":"1478-3223","type":"print"},{"value":"1478-3231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9,22]]}}}